Sorrento’s biotech buyouts bag CAR-T drugs

Sorrento Therapeutics, closely allied with Patrick Soon-Shiong’s fast-growing oncology drug empire, has bagged two private biotech companies, adding some CAR-T therapies to the mix.

Source: www.fiercebiotech.com



Comments are closed.